Orion Biotech Opportunities Corp.
DelistedCIK 1847416fmd_1RSK1BFHQ8M9WHDRJMZ1M2PF7BFinance, Insurance and Real Estate · Blank ChecksTemplate: Standard
Coverage: Apr 01, 2021 to Dec 31, 2022, 6 periods
Latest annual · FY2022
Millions- Operating income
- (1)
- Net income
- 9
Latest quarter · Q4 FY2022
Millions- Operating income
- (0)
- Net income
- 1
Orion Biotech Opportunities Corp. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | Change | Source | |
|---|---|---|---|---|
| Operating income | -$899,674 | 10-K 2023-03-29 · proof | ||
| Net income | $8.8 million | 10-K 2023-03-29 · proof | ||
| Cash from operating activities | -$376,757 | 10-K 2023-03-29 · proof | ||
| Total assets | $203.3 million | 10-K 2023-03-29 · proof | ||
| Total liabilities | $8.3 million | 10-K 2023-03-29 · proof | ||
| Cash and cash equivalents | $265,717 | 10-K 2023-03-29 · proof |
- What was Orion Biotech Opportunities Corp.'s operating income in fiscal 2022?
- Orion Biotech Opportunities Corp. reported operating income of -$899,674 for fiscal 2022 (the year ended Dec 31, 2022). Source: the 10-K filed with the SEC on Mar 29, 2023. SEC
- What was Orion Biotech Opportunities Corp.'s net income in fiscal 2022?
- Orion Biotech Opportunities Corp. reported net income of $8.8 million for fiscal 2022 (the year ended Dec 31, 2022). Source: the 10-K filed with the SEC on Mar 29, 2023. SEC
- What was Orion Biotech Opportunities Corp.'s cash from operating activities in fiscal 2022?
- Orion Biotech Opportunities Corp. reported cash from operating activities of -$376,757 for fiscal 2022 (the year ended Dec 31, 2022). Source: the 10-K filed with the SEC on Mar 29, 2023. SEC
- What are Orion Biotech Opportunities Corp.'s total assets?
- As of Dec 31, 2022, Orion Biotech Opportunities Corp. reported total assets of $203.3 million. Source: the 10-K filed with the SEC on Mar 29, 2023. SEC
- What are Orion Biotech Opportunities Corp.'s total liabilities?
- As of Dec 31, 2022, Orion Biotech Opportunities Corp. reported total liabilities of $8.3 million. Source: the 10-K filed with the SEC on Mar 29, 2023. SEC
- What are Orion Biotech Opportunities Corp.'s cash and cash equivalents?
- As of Dec 31, 2022, Orion Biotech Opportunities Corp. reported cash and cash equivalents of $265,717. Source: the 10-K filed with the SEC on Mar 29, 2023. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1847416&period_type=annual&limit=5"Information only, not investment advice.